González A, Noda J, Vega A, Venereo A, Rodríguez E, Rodríguez MP, González EM, Díaz D, Montesino R, Santana E, Montero C, Rodríguez A, Estrada MP, Borroto C

Language: English
References: 15
Page: 275-278
PDF size: 184.42 Kb.

ABSTRACT

The highly pathogenic H5N1 avian influenza virus (AIV) has caused important economic losses and public health problems, mainly in Asia, Africa and Europe. Counteracting this virus by vaccination of poultry is crucial. In our study, recombinant antigens based on the fusion of the extracellular segments of both molecules, hemagglutinin H5 of AIV and the chicken CD154, were tested to enhance the immune response in chickens. For this purpose, chickens were immunized with recombinant adenoviral vectors carrying the nucleotide sequence of the hemagglutinin H5 alone (AdHA) or fused to the CD154 recombinant protein (AdHACD). Also, these two proteins (rHA and rHACD) were produced and assayed as antigens. Both, the adenoviral vector AdHACD and the recombinant protein rHACD, induced hemagglutination-inhibiting antibody titers significantly higher than their counterparts carrying HA alone. Similar results were observed when the cellular response was measured by real time PCR. AdHACD and rHACD significantly increased the production of IFN-γ transcripts, which were lower when AdHA or rHA were used. To obtain a higher quality antigen, rHACD was purified by size exclusion chromatography, resulting in the preservation of its immunogenic properties. However, rHACD did not work as immunogen when an immunoaffinity chromatography was performed by eluting at acidic pH or with a chaotropic agent. These results demonstrate that chicken CD154 can significantly enhance humoral and cellular responses against hemagglutinin H5 of AIV when both molecules are administered as a fusion protein in chickens. Therefore, AdHACD or rHACD could become promising vaccine candidates against H5N1 virus.

REFERENCES

1. Buscaglia C. Influenza Aviar. InVet. 2004;6(1):71-84.

2. Suguitan AL, Jr, Cheng X, Wang W, Wang S, Jin H, Lu S. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. PLoS One. 2011;6(7):e21942.

3. Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev. 2001;14(1):129-49.

4. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine. 2002;20(25-26):3165-70.

5. McPherson CE. Development of a novel recombinant influenza vaccine in insect cells. Biologicals. 2008;36(6):350-3.

6. Pentcheva-Hoang T, Corse E, Allison JP. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol Rev. 2009;229(1):67-87.

7. Gray D, Siepmann K, Wohlleben G. CD40 ligation in B cell activation, isotype switching and memory development. Semin Immunol. 1994;6(5):303-10.

8. Li W. Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen. Immunology. 2005;115(2):215-22.

9. Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol. 2006;80(4):1762-72.

10. Fischer KP, Gares SL, Wang D, Lorne Tyrrell D, Gutfreund KS. Identification and characterization of functional CD154 (CD40 ligand) in the Pekin duck. Dev Comp Immunol. 2007;31(1):61-71.

11. Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol. 2000;1(2):127-31.

12. Sanchez Ramos O, Gonzalez Pose A, Gomez-Puerta S, Noda Gomez J, Vega Redondo A, Aguila Benites JC, et al. Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens. Comp Immunol Microbiol Infect Dis. 2011;34(3):259-65.

13. Pose AG, Gomez JN, Sanchez AV, Redondo AV, Rodriguez ER, Segui RM, et al. Subunit influenza vaccine candidate based on CD154 fused to HAH5 increases the antibody titers and cellular immune response in chickens. Vet Microbiol. 2011;152(3-4):328-37.

14. Peitsch MC, Jongeneel CV. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol. 1993;5(2):233-8.

15. Gaudin Y, Ruigrok RW, Brunner J. Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. J Gen Virol. 1995;76(Pt 7):1541-56.